AKEBIA THERAPEUTICS INC's ticker is AKBA and the CUSIP is 00972D105. A total of 79 filers reported holding AKEBIA THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 0.47 and the average weighting 0.4%.
Links
Filings
- All filings
- Annual reports (10-K)
- Quarterly reports (10-Q)
- Insider transactions
- Shareholder votes
- Significant ownership
- Events
EDGAR links
External links
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $344,418 | +17.3% | 302,121 | -5.9% | 0.00% | – |
| Q2 2023 | $293,677 | +40.7% | 320,958 | -13.8% | 0.00% | – |
| Q1 2023 | $208,726 | +0.7% | 372,458 | +3.7% | 0.00% | – |
| Q4 2022 | $207,206 | +81.8% | 359,110 | -0.3% | 0.00% | – |
| Q3 2022 | $114,000 | -10.2% | 360,345 | -0.1% | 0.00% | – |
| Q2 2022 | $127,000 | -89.4% | 360,526 | -78.5% | 0.00% | – |
| Q1 2022 | $1,203,000 | -69.5% | 1,676,121 | -4.0% | 0.00% | -100.0% |
| Q4 2021 | $3,947,000 | -22.7% | 1,746,054 | -1.5% | 0.00% | 0.0% |
| Q3 2021 | $5,104,000 | -20.3% | 1,772,171 | +4.8% | 0.00% | 0.0% |
| Q2 2021 | $6,408,000 | +14.3% | 1,690,808 | +2.1% | 0.00% | 0.0% |
| Q1 2021 | $5,606,000 | +14.6% | 1,656,239 | -5.2% | 0.00% | 0.0% |
| Q4 2020 | $4,893,000 | +8.8% | 1,747,611 | -2.5% | 0.00% | 0.0% |
| Q3 2020 | $4,497,000 | -81.3% | 1,791,692 | +1.0% | 0.00% | -83.3% |
| Q2 2020 | $24,087,000 | +116.5% | 1,773,715 | +20.8% | 0.01% | +100.0% |
| Q1 2020 | $11,126,000 | +19.6% | 1,467,877 | -0.3% | 0.00% | +50.0% |
| Q4 2019 | $9,302,000 | +65.4% | 1,471,994 | +2.6% | 0.00% | +100.0% |
| Q3 2019 | $5,624,000 | +0.8% | 1,434,840 | +24.5% | 0.00% | 0.0% |
| Q2 2019 | $5,578,000 | -39.3% | 1,152,582 | +2.8% | 0.00% | -50.0% |
| Q1 2019 | $9,187,000 | +55.9% | 1,121,546 | +5.3% | 0.00% | 0.0% |
| Q4 2018 | $5,892,000 | +5.2% | 1,065,381 | +67.9% | 0.00% | +100.0% |
| Q3 2018 | $5,601,000 | -8.5% | 634,396 | +3.5% | 0.00% | -50.0% |
| Q2 2018 | $6,120,000 | +23.8% | 613,187 | +18.2% | 0.00% | +100.0% |
| Q1 2018 | $4,944,000 | -35.2% | 518,839 | +1.0% | 0.00% | -50.0% |
| Q4 2017 | $7,635,000 | -24.7% | 513,456 | -0.3% | 0.00% | -33.3% |
| Q3 2017 | $10,133,000 | +66.3% | 515,155 | +21.5% | 0.00% | +50.0% |
| Q2 2017 | $6,094,000 | +79.8% | 424,093 | +15.1% | 0.00% | +100.0% |
| Q1 2017 | $3,389,000 | -11.0% | 368,330 | +0.7% | 0.00% | 0.0% |
| Q4 2016 | $3,807,000 | +11.5% | 365,650 | -3.1% | 0.00% | 0.0% |
| Q3 2016 | $3,415,000 | +23.0% | 377,378 | +1.7% | 0.00% | 0.0% |
| Q2 2016 | $2,776,000 | -2.6% | 371,104 | +17.4% | 0.00% | 0.0% |
| Q1 2016 | $2,849,000 | -7.5% | 316,149 | +32.6% | 0.00% | 0.0% |
| Q4 2015 | $3,080,000 | +36.7% | 238,387 | +2.2% | 0.00% | 0.0% |
| Q3 2015 | $2,253,000 | +66.4% | 233,242 | +77.2% | 0.00% | – |
| Q2 2015 | $1,354,000 | +50.6% | 131,640 | +62.8% | 0.00% | – |
| Q1 2015 | $899,000 | -3.5% | 80,884 | +1.0% | 0.00% | – |
| Q4 2014 | $932,000 | -47.0% | 80,103 | +0.9% | 0.00% | -100.0% |
| Q3 2014 | $1,757,000 | +204.5% | 79,418 | +282.5% | 0.00% | – |
| Q2 2014 | $577,000 | – | 20,761 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Alerce Investment Management, L.P. | 4,652,561 | $13,027,000 | 5.13% |
| Orchard Capital Management, LLC | 857,138 | $2,400,000 | 1.02% |
| Nantahala Capital Management | 7,040,487 | $19,713,000 | 0.61% |
| OCCUDO QUANTITATIVE STRATEGIES LP | 209,040 | $585,000 | 0.18% |
| Woodline Partners LP | 2,382,522 | $6,671,000 | 0.18% |
| RICE HALL JAMES & ASSOCIATES, LLC | 1,546,169 | $4,329,000 | 0.15% |
| Virtus ETF Advisers LLC | 92,771 | $260,000 | 0.11% |
| Jump Financial, LLC | 155,583 | $435,000 | 0.07% |
| GSA CAPITAL PARTNERS LLP | 128,626 | $360,000 | 0.06% |
| Anson Funds Management LP | 95,342 | $267,000 | 0.05% |